Ishara Investments LP - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Ishara Investments LP held in its portfolio 38 assets valued at $87,455,205 (i.e. $87.46M).
The most valuable assets in the portfolio included: PRAXIS PRECISION MEDICINES I ($11.79M), XERIS BIOPHARMA HOLDINGS INC ($6.28M), and BIOMARIN PHARMACEUTICAL INC ($5.94M).
The chart below shows the top 10 valuable assets, and the table below shows the top 38 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Ishara Investments LP - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | 40000 | 11789600 | COM NEW |
| XERIS BIOPHARMA HOLDINGS INC | 800000 | 6280000 | COM |
| BIOMARIN PHARMACEUTICAL INC | 100000 | 5943000 | COM |
| AMICUS THERAPEUTICS INC | 360000 | 5126400 | COM |
| ACADIA PHARMACEUTICALS INC | 160000 | 4273600 | COM |
| ANNEXON INC | 750000 | 3765000 | COM |
| NUVATION BIO INC | 400000 | 3584000 | COM CL A |
| BRIDGEBIO PHARMA INC | 36000 | 2753640 | COM |
| PTC THERAPEUTICS INC | 36000 | 2734560 | COM |
| UNITED THERAPEUTICS CORP DEL | 5500 | 2679875 | COM |
| BIOCRYST PHARMACEUTICALS INC | 300000 | 2340000 | COM |
| VAXCYTE INC | 50000 | 2307000 | COM |
| GENMAB A/S | 70000 | 2156000 | SPONSORED ADS |
| SYNDAX PHARMACEUTICALS INC | 100000 | 2101000 | COM |
| VERASTEM INC | 270000 | 2084400 | COM NEW |
| TARSUS PHARMACEUTICALS INC | 24000 | 1965120 | COM |
| APOGEE ENTERPRISES INC | 25000 | 1887000 | COM |
| ZENTALIS PHARMACEUTICALS INC | 1320000 | 1782000 | COM |
| INSMED INC | 10000 | 1740400 | COM PAR $.01 |
| CORCEPT THERAPEUTICS INC | 44000 | 1531200 | COM |
| SILENCE THERAPEUTICS PLC | 240000 | 1459200 | ADS |
| EDGEWISE THERAPEUTICS INC | 58000 | 1439270 | COM |
| BEAM THERAPEUTICS INC | 50000 | 1386000 | COM |
| ORIC PHARMACEUTICALS INC | 160000 | 1308800 | COM |
| APELLIS PHARMACEUTICALS INC | 50000 | 1256000 | COM |
| DENALI THERAPEUTICS INC | 70000 | 1155700 | COM |
| ULTRAGENYX PHARMACEUTICAL IN | 50000 | 1150000 | COM |
| ASCENDIS PHARMA A/S | 5000 | 1066200 | SPONSORED ADR |
| NEWAMSTERDAM PHARMA COMPANY | 30000 | 1052400 | ORDINARY SHARES |
| LEXICON PHARMACEUTICALS INC | 880000 | 1012000 | COM NEW |
| BIOHAVEN LTD | 88000 | 993520 | COM |
| DIANTHUS THERAPEUTICS INC | 24000 | 989040 | COM |
| NEKTAR THERAPEUTICS | 20000 | 845600 | COM NEW |
| IMMATICS N.V | 80000 | 840000 | SHS |
| AGIOS PHARMACEUTICALS INC | 30000 | 816600 | COM |
| IMMUNOVANT INC | 30000 | 762600 | COM |
| OLEMA PHARMACEUTICALS INC | 30000 | 750000 | COM |
| ARCUTIS BIOTHERAPEUTICS INC | 12000 | 348480 | COM |